Both in Pharmaceuticals
Prothena vs Gyre Therapeutics
Over the past year PRTA returned −18.2% and GYRE returned −38.8%; their daily moves had a correlation of 0.31.
PRTA −18.2% GYRE −38.8%Growth of $1, one year, split-adjusted
| Metric | PRTA | GYRE |
|---|---|---|
| Price | $8.39 | $4.44 |
| Market cap | $430.7M | $470.8M |
| Today | +2.19% | 0.00% |
| 1 month | +4.6% | −37.3% |
| 6 months | −25.0% | −44.8% |
| Year to date | −12.1% | −37.1% |
| 1 year | −20.4% | −39.7% |
| Revenue growth (YoY) | −77.1% | −2.1% |
| Gross margin | 100.0% | 92.4% |
| Net margin | −1839.9% | −40.1% |
| P/E (TTM) | — | — |
| Price / sales | 7.9× | 3.9× |
| Net cash | $288.2M | $74.8M |
| Dividend yield | — | — |
| Volatility (60d) | 45.9% | 88.3% |
| Short % of float | 18.9% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).